Focused ultrasound controls prostate cancer with fewer side effects: study
The tissue-preserving approach could eliminate the need for radical whole-gland treatment, researchers say
MRI-guided focused ultrasound focal therapy leads to effective disease control without compromising safety in patients with intermediate-risk prostate cancer, a study shows.
The quality-of-life outcomes associated with the new treatment strategy also compare favourably with existing treatments including radical prostatectomy and radiation therapy, the US researchers say.
In the single-arm, multicentre trial, the authors analysed data from 101 men (median age 63) with unilateral and previously untreated prostate cancer treated with MRI-guided focused ultrasound focal therapy.
Participants had grade group-2 or 3 cancer and the average concentration of prostate specific antigen was 5.7ng/mL.
